AVENUE THERAPEUTICS INC's ticker is and the CUSIP is 05360L304. A total of 12 filers reported holding AVENUE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 553,338 | $647,405 | 0.53% |
| EMFO, LLC | 533 | $624 | 0.00% |
| WELLS FARGO & COMPANY/MN | 4,585 | $5,365 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 52,571 | $60,456 | 0.00% |
| STATE STREET CORP | 30,593 | $35,182 | 0.00% |
| BARRETT & COMPANY, INC. | 15 | $17 | 0.00% |
| MORGAN STANLEY | 414 | $484 | 0.00% |
| BlackRock Inc. | 1,942 | $2,272 | 0.00% |
| Bank of New York Mellon Corp | 52,986 | $61,994 | 0.00% |
| Tower Research Capital LLC (TRC) | 5,629 | $6,586 | 0.00% |
| ROYAL BANK OF CANADA | 52 | $0 | 0.00% |
This page lists AVENUE THERAPEUTICS INC's shareholders in Q2 2023. To view AVENUE THERAPEUTICS INC's shareholder history, click here.